EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effective Targeting of Glutamine Synthetase with Amino Acid Analogs as a Novel Therapeutic Approach in Breast Cancer

Shimaa Abdelsattar iD, Hiba S Al-Amodi iD, Hala F Kamel iD, Ahood A Al-Eidan iD, Marwa M Mahfouz, Kareem El Khashab, Amany M Elshamy, Mohamed S Basiouny iD, Mohamed A Khalil iD, Khaled A Elawdan, Shorouk Elsaka, Salwa E Mohamed iD und 1 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shimaa Abdelsattar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biochemistry and Molecular Diagnostics Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Glutamate-Ammonia Ligase, Amino Acids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells undergo metabolic rewiring to support rapid proliferation and survival in challenging environments. Glutamine is a preferred resource for cancer metabolism, as it provides both carbon and nitrogen for cellular biogenesis. Recent studies suggest the potential anticancer activity of amino acid analogs. Some of these analogs disrupt cellular nucleotide synthesis, thereby inhibiting the formation of DNA and RNA in cancer cells. In the present study, we investigated the anticancer properties of Acivicin and Azaserine in the breast cancer MCF-7 cell line, comparing their effects to those on the non-tumorigenic MCF-10 epithelial cell line in vitro. Interestingly, at lower concentrations, both Acivicin and Azaserine showed potent inhibition of MCF-7 cell proliferation, as assessed by the MTT assay, without detectable toxicity to normal cells. In contrast, Sorafenib (Nexavar), a commonly used drug for solid tumors, showed harmful effects on normal cells, as indicated by increased lactate dehydrogenase (LDH) production in treated cells. Furthermore, unlike Sorafenib, treatment with Acivicin and Azaserine significantly affected apoptotic signaling in treated cells, indicating the role of both amino acid analogs in activating programmed cell death (PCD), as assessed by the Annexin-V assay, DAPI staining, and the relative expression of tumor suppressor genes PTEN and P53. ELISA analysis of MCF-7 cells revealed that both Acivicin and Azaserine treatments promoted the production of anti-inflammatory cytokines, including IL-4 and IL-10, while significantly reducing the production of tumor necrosis factor alpha (TNF-α). Mechanistically, both Acivicin and Azaserine treatment led to a significant reduction in the expression of glutamine synthetase (GS) at both the RNA and protein levels, resulting in a decrease in intracellular glutamine concentrations over time. Additionally, both treatments showed comparable effects on Raf-1 gene expression and protein phosphorylation when compared with Sorafenib, a Raf-1 inhibitor. Moreover, docking studies confirmed the strong binding affinity between Acivicin, Azaserine, and glutamine synthetase, as evidenced by their docking scores and binding interactions with the enzyme crystal. Collectively, these findings provide evidence for the anticancer activity of the two amino acid analogs Acivicin and Azaserine as antagonists of glutamine synthetase, offering novel insights into potential therapeutic strategies for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic AgentsGlutamate-Ammonia LigaseAmino AcidsHumansFemaleMCF-7 CellsCell ProliferationApoptosisCell Line, TumorMolecular Docking Simulation

Stichwörter der Autor:innen

acivicinamino acid analogsazaserinebreast cancerglutamine synthetase

Substanzen

Antineoplastic AgentsGlutamate-Ammonia LigaseAmino Acids

Autor:innen und Institutionen

  • Clinical Biochemistry and Molecular Diagnostics Department, National Liver Institute, Menoufia University, Shebin El-Kom 32511, Egypt.
  • Biochemistry Department, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
  • Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Ain Shams University, Cairo 11591, Egypt.
  • Department of Biology, College of Science, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Menoufia University, Shebin El-Kom 32511, Egypt.
  • Medical Laboratory Department, High Technology Institute of Applied Health Science, Badr Academy for Science and Technology, Badr City 11829, Egypt.

ORCID-Profile: Shimaa Abdelsattar, Hiba S Al-Amodi, Hala F Kamel, Ahood A Al-Eidan, Mohamed S Basiouny, Mohamed A Khalil, Salwa E Mohamed, Hany Khalil

Zitieren

APA

Abdelsattar, S., Al-Amodi, H. S., Kamel, H. F., Al-Eidan, A. A., Mahfouz, M. M., El Khashab, K., Elshamy, A. M., Basiouny, M. S., Khalil, M. A., Elawdan, K. A., Elsaka, S., Mohamed, S. E., & Khalil, H. (2024). Effective Targeting of Glutamine Synthetase with Amino Acid Analogs as a Novel Therapeutic Approach in Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010078

Vancouver

Abdelsattar S, Al-Amodi HS, Kamel HF, Al-Eidan AA, Mahfouz MM, El Khashab K, et al. Effective Targeting of Glutamine Synthetase with Amino Acid Analogs as a Novel Therapeutic Approach in Breast Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010078

BibTeX
@article{Abdelsattar2024,
  author = {Abdelsattar, Shimaa and Al-Amodi, Hiba S and Kamel, Hala F and Al-Eidan, Ahood A and Mahfouz, Marwa M and El Khashab, Kareem and Elshamy, Amany M and Basiouny, Mohamed S and Khalil, Mohamed A and Elawdan, Khaled A and Elsaka, Shorouk and Mohamed, Salwa E and Khalil, Hany},
  title = {Effective Targeting of Glutamine Synthetase with Amino Acid Analogs as a Novel Therapeutic Approach in Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010078}
}
Kostenlos starten →